NM_173841.3(IL1RN):c.10+18dup AND Sterile multifocal osteomyelitis with periostitis and pustulosis

Germline classification:: Likely benign (1 submission)
Last evaluated:: Jul 12, 2023
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003865506.2

Allele description [Variation Report for NM_173841.3(IL1RN):c.10+18dup]

NM_173841.3(IL1RN):c.10+18dup

Gene:

IL1RN:interleukin 1 receptor antagonist [Gene - OMIM - HGNC]

Variant type:

Duplication

Cytogenetic location:

2q14.1

Genomic location:

Preferred name:

NM_173841.3(IL1RN):c.10+18dup

HGVS:

NC_000002.12:g.113118046dup
NG_021240.1:g.5154dup
NM_000577.5:c.10+18dup
NM_001318914.2:c.-273+18dup
NM_173841.3:c.10+18dup
NM_173843.3:c.-210+18dup
LRG_188:g.5154dup
NC_000002.11:g.113875622_113875623insT
NC_000002.11:g.113875623dup

Molecular consequence:

NM_000577.5:c.10+18dup - intron variant - [Sequence Ontology: SO:0001627]
NM_001318914.2:c.-273+18dup - intron variant - [Sequence Ontology: SO:0001627]
NM_173841.3:c.10+18dup - intron variant - [Sequence Ontology: SO:0001627]
NM_173843.3:c.-210+18dup - intron variant - [Sequence Ontology: SO:0001627]

Condition(s)

Name:: Sterile multifocal osteomyelitis with periostitis and pustulosis
Synonyms:: CHRONIC RECURRENT MULTIFOCAL OSTEOMYELITIS 2, WITH PERIOSTITIS AND PUSTULOSIS
Identifiers:: MONDO: MONDO:0013021; MedGen: C2748507; Orphanet: 210115; OMIM: 612852

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004663521	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Likely benign (Jul 12, 2023)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004663521

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Likely benign
(Jul 12, 2023)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004663521.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Nov 3, 2024

ClinVar

Relating variation to medicine